Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract

• Published in: Folia microbiologica Vol. 65; no. 2; pp. 245 - 264
• Main Authors: Bustamante, Mariela, Oomah, B. Dave, Oliveira, Wanderley P., Burgos-Díaz, César, Rubilar, Mónica, Shene, Carolina
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.04.2020; Springer Nature B.V
• Subjects: Applied Microbiology; Biomedical and Life Sciences; Consumption; Digestive system; Eczema; Environmental Engineering/Biotechnology; Evaluation; Females; Immunology; Infectious diseases; Lactation; Life Sciences; Medical treatment; Microbial activity; Microbiology; Microorganisms; Prebiotics; Pregnancy; Probiotics; Respiratory tract; Respiratory tract diseases; Review; Skin diseases; Standardization; Synergistic effect; Urinary tract; Respiratory tract; Probiotics; Skin; Female urogenital system; Prebiotics
• ISSN: 0015-5632; 1874-9356
• DOI: 10.1007/s12223-019-00759-3

The prebiotics and probiotics market is constantly growing due to the positive effects of its consumption on human health, which extends beyond the digestive system. In addition, the synbiotic products market is also expanding due to the synergistic effects between pre- and probiotics that provide additional benefits to consumers. Pre- and probiotics are being evaluated for their effectiveness to treat and prevent infectious diseases in other parts of the human body where microbial communities exist. This review examines the scientific data related to the effects of pre- and probiotics on the treatment of diseases occurring in the skin, female urogenital tract, and respiratory tract. The evidence suggests that probiotics consumption can decrease the presence of eczema in children when their mothers have consumed probiotics during pregnancy and lactation. In women, probiotics consumption can effectively prevent recurrent urinary tract infections. The consumption of synbiotic products can reduce respiratory tract infections and their duration and severity. However, the outcomes of the meta-analyses are still limited and not sufficiently conclusive to support the use of probiotics to treat infectious diseases. This is largely a result of the limited number of studies, lack of standardization of the studies, and inconsistencies between the reported results. Therefore, it is advisable that future studies consider these shortcomings and include the evaluation of the combined use of pre- and probiotics.